To directly explore a role for SMYD3 in SCLC responses to chemotherapy, we generated conditional Smyd3LoxP/LoxP-mutant mice (18) crossed with the TKO cancer model (TKO;Smyd3; Fig. 7A; Supplementary Fig. S7D and S7E). The gene discussed is SMYD3; the disease is small cell lung carcinoma.